MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
common stock and...
$5,215K
Proceeds from the sale of
common stock under atm
$154K
Net cash provided by
financing activities
$5,369K
Net decrease in cash
and restricted cash
-$2,835K
Canceled cashflow
$5,369K
Tax credit
receivable
-$509K
Right of use assets
$304K
Stock-based compensation
$270K
Prepaid expenses and
other current assets
-$102K
Depreciation and
amortization expense
$72K
Net cash used in
operating activities
-$8,192K
Canceled cashflow
$1,257K
Net cash used in
investing activities
-$12K
Net loss
-$8,831K
Change in operating
lease liabilities
$301K
Accounts payable and
accrued expenses
-$251K
Deposits
$66K
Purchases of property and
equipment
$12K
Back
Back
Cash Flow
source: myfinsight.com
Cocrystal Pharma, Inc. (COCP)
Cocrystal Pharma, Inc. (COCP)